Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study Of Upadacitinib in Ulcerative Colitis in China

NCT06838845 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06838845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06838845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study Of Upadacitinib in Ulcerative Colitis in China
Lead sponsor
AbbVie
Phase
Observational
Overall status
Recruiting
Start date
April 9, 2025
Completion date
December 31, 2026
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis